Buy Biocon, target Rs 272 : Kunal Bothra
Buy Biocon Ltd. at a price target of Rs 272 and a stoploss at Rs 258 from entry point.
Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 2639.20 Crore to Sales Value (91.48 % of Total Sales), Other Operating Revenue which contributed Rs 229.40 Crore to Sales Value (7.95 % of Total Sales), Waste which contributed Rs 15.10 Crore to Sales Value (0.52 % of Total Sales) and Sale of services which contributed Rs 1.00 Crore to Sales Value (0.03 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 31-03-2019, the company has reported a Consolidated sales of Rs 1528.80 Crore, down -.78 % from last quarter Sales of Rs 1540.80 Crore and up 30.72 % from last year same quarter Sales of Rs 1169.50 Crore Company has reported net profit after tax of Rs 254.60 Crore in latest quarter. The company’s top management includes Dr.Arun Chandavarkar, Dr.Jeremy Levin, Dr.Vijay Kuchroo, Mr.Bobby Kanubhai Parikh, Mr.Daniel M Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar. Company has B S R & Co. LLP as its auditoRs As on 20-06-2019, the company has a total of 1,200,000,000 shares outstanding.